Stay updated on DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check35 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No substantive content changes are visible.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a new site revision note: v3.4.2. The notices about government funding lapse and the older revision v3.4.1 were removed.SummaryDifference0.4%

- Check71 days agoChange DetectedThe page now includes a government funding lapse notice and a new revision label v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check78 days agoChange DetectedShow glossary added and minor wording/capitalization changes to update metadata (e.g., 'Last Update Submitted that Met QC Criteria' vs 'Last Update Submitted that met QC Criteria'; 'No FEAR Act Data' vs 'No FEAR Act data'), plus 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision tag updated: added v3.3.4 and removed v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.